Advancing Treatment for Glaucoma
We’re EyeLight, Inc., and we’re proud to be innovators of the highest standard, using cutting-edge technologies to lead innovation in ELT (Excimer Laser Trabeculostomy) surgery. To simplify, it is a life changing procedure like LASIK but for Glaucoma patients. Through meticulous and reliable work, our company has developed a minimally invasive (MIGS), outpatient surgical procedure which corrects the anatomic pathology responsible for most open-angle glaucoma.
Advantages of Excimer Laser Trabeculostomy
Minimally invasive (MIGS)
No foreign bodies implanted
Sustained lower IOP
No hypotony
No pressure spikes
Non-thermal UV tissue removal
Minimizes risk of scarring
Preserves limbal tissue
If ever needed for future procedures
No blebs created
Performed in ¼ the time of trabeculectomy
With significantly less post-op monitoring needed
Technology
A minimally invasive (MIGS), outpatient surgical procedure which corrects the anatomic pathology responsible for most open-angle glaucoma: outflow obstruction at the juxtacanalicular trabecular meshwork and the inner wall of Schlemm’s canal.
Glaucoma Treatment
Excimer Laser Trabeculostomy (ELT)
Medical Results
Current solutions are costly, less effective and involve invasive surgery
ELT is the innovative solution that provides better results for patients
Testing is the foundational element of all medical innovation, and we already have extensive experience with the slution
